DPLPharmaceuticals
Dipna Pharmachem Ltd — Cash Flow Statement
₹8.02
-2.59%
Dipna Pharmachem Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -9.21 Cr | -5.43 Cr | -20.99 Cr | 2.80 Cr | — |
| Issuance Of Capital Stock | 0.00 | 12.08 Cr | 21.71 Cr | 0.00 | — |
| Capital Expenditure | -0.02 Cr | -0.01 Cr | -0.01 Cr | -67712.00 | — |
| End Cash Position | 0.43 Cr | 13.88 Cr | 5.69 Cr | 0.21 Cr | — |
| Beginning Cash Position | 13.88 Cr | 5.69 Cr | 0.21 Cr | 0.25 Cr | — |
| Changes In Cash | -13.45 Cr | 8.19 Cr | 5.48 Cr | -0.04 Cr | — |
| Financing Cash Flow | -4.24 Cr | 13.62 Cr | 26.47 Cr | -2.84 Cr | — |
| Interest Paid Cff | -2.02 Cr | -2.00 Cr | -0.96 Cr | -0.61 Cr | — |
| Net Common Stock Issuance | 0.00 | 12.08 Cr | 21.71 Cr | 0.00 | — |
| Common Stock Issuance | 0.00 | 12.08 Cr | 21.71 Cr | 0.00 | — |
| Net Issuance Payments Of Debt | -2.22 Cr | 3.54 Cr | 5.72 Cr | -2.24 Cr | — |
| Net Short Term Debt Issuance | 1.43 Cr | 1.96 Cr | -2.66 Cr | -1.88 Cr | — |
| Net Long Term Debt Issuance | -3.66 Cr | 1.58 Cr | 5.72 Cr | -2.24 Cr | — |
| Investing Cash Flow | -0.02 Cr | -0.01 Cr | -0.01 Cr | -67712.00 | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -0.02 Cr | -0.01 Cr | -0.01 Cr | -67712.00 | — |
| Purchase Of PPE | -0.02 Cr | -0.01 Cr | -0.01 Cr | -67712.00 | — |
| Operating Cash Flow | -9.19 Cr | -5.42 Cr | -20.98 Cr | 2.81 Cr | — |
| Taxes Refund Paid | -0.45 Cr | -0.34 Cr | -0.47 Cr | -0.41 Cr | — |
| Interest Paid Cfo | 0.00 | 0.00 | 0.00 | -0.41 Cr | — |
| Dividend Paid Cfo | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | -12.20 Cr | -8.51 Cr | -22.86 Cr | 1.03 Cr | — |
| Change In Other Current Liabilities | 0.20 Cr | 0.06 Cr | -0.73 Cr | 0.87 Cr | — |
| Change In Other Current Assets | -7.53 Cr | -26.32 Cr | -21.65 Cr | -0.34 Cr | — |
| Change In Payable | 1.19 Cr | 38.25 Cr | 12.99 Cr | 12.51 Cr | — |
| Change In Inventory | 9.95 Cr | -18.44 Cr | -12.64 Cr | 0.89 Cr | — |
| Change In Receivables | -15.34 Cr | -2.40 Cr | -1.56 Cr | -12.03 Cr | — |
| Other Non Cash Items | 2.02 Cr | 2.00 Cr | 0.96 Cr | 0.61 Cr | — |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation And Amortization | 0.01 Cr | 0.02 Cr | 0.01 Cr | 62014.00 | — |
| Depreciation | 0.01 Cr | 0.02 Cr | 0.01 Cr | 62014.00 | — |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | 1.42 Cr | 1.42 Cr | 1.38 Cr | 1.57 Cr | — |
| Issuance Of Debt | — | 3.54 Cr | 5.72 Cr | — | 2.86 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | — | 1000.00 | — |
| Net Other Financing Charges | — | -1000.00 | — | — | — |
| Long Term Debt Issuance | — | 3.54 Cr | 5.72 Cr | — | 0.32 Cr |
| Net Business Purchase And Sale | — | — | 0.00 | 0.00 | — |
| Purchase Of Business | — | — | 0.00 | 0.00 | — |
| Sale Of PPE | — | — | 0.00 | 0.00 | — |
| Repayment Of Debt | — | — | — | -2.24 Cr | — |
| Short Term Debt Payments | — | — | — | -1.88 Cr | — |
| Long Term Debt Payments | — | — | — | -2.24 Cr | — |
| Interest Received Cfi | — | — | — | 86000.00 | 95000.00 |
| Short Term Debt Issuance | — | — | — | — | 2.53 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dipna Pharmachem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.